Skip to main content

Find Clinical Trials

Home
Conditions
Endocrine Gland Neoplasms

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,097 public trials 1,370 recruiting studies

Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery

NCT00410553

Conditions: Adnexal Diseases, Adult Solid Neoplasm, Endocrine Gland Neoplasms, +19 more
Locations: Ottawa Hospital-Civic Campus Ottawa, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

PACE4 in Thyroid Cancer

NCT03160482

Conditions: Endocrine Gland Neoplasms, Endocrine System Diseases, Head and Neck Neoplasms, +5 more
Locations: CIUSSS de l'Estrie - CHUS Sherbrooke, Quebec, Canada

View Trial Details

Completed

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

NCT00030706

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
Locations: Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx, New York, United States

View Trial Details

Completed

Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer

NCT01358071

Conditions: Adnexal Diseases, Disease Attributes, Disease Progression, +19 more
Locations: Ospedale San Raffaele Milan, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

Istituto Europeo di Oncologia Milan, Italy

Istituto Nazionale Tumori IRCCS Fondazione "Giovanni Pascale" Naples, Italy

View Trial Details

Completed

Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer

NCT00484432

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Fondazione San Raffaele del Monte Tabor Milan, Italy

Policlinico Universitario A. Gemelli Rome, Italy

View Trial Details

Completed

Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer

NCT00557492

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Pittsburgh Medical Centers Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Androgen for Leydig Cell Proliferation

NCT01206270

Conditions: Chromosome Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations: Dipartimento di Fisiopatologia Medica Rome, Lazio, Italy

View Trial Details

Completed

A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

NCT01663272

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer

NCT02399137

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Banner MD Anderson Cancer Ctr. Gilbert, Arizona, United States

Pacific Cancer Medical Center, Inc. Anaheim, California, United States

St. Jude Heritage Healthcare Fullerton, California, United States

UCLA School of Medicine Los Angeles, California, United States

View all 66 locations

View Trial Details

Completed

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy as First-Line Treatment in Patients With Advanced Ovarian Cancer (OSCAR 1)

NCT01863693

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Royal United Hospital; Oncology Department Bath, United Kingdom

City Hospital Birmingham, United Kingdom

Bradford Royal Infirmary; Oncology Department Bradford, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

View all 30 locations

View Trial Details